Role of sirtuin 6 in early vascular aging in young and middle-aged patients with coronary artery disease (literature review)
https://doi.org/10.15829/1728-8800-2025-4370
EDN: OCWUBS
Abstract
Coronary artery disease (CAD) remains the leading cause of disability and high mortality, including among working-age people. One of the most common causes of CAD in young people is early vascular aging (EVA). Studying the regulatory role of sirtuin 6 in the development of EVA seems relevant. The purpose of the review was to analyze the literature data on the possible influence of sirtuin 6 on EVA in young and middle-aged patients with CAD. For this purpose, we searched data in international (PubMed, Scopus, Web of Science and Cochrane Library) and Russian (eLIBRARY and CyberLeninka) databases. Particular attention was paid to works published over the past 15 years, with an emphasis on studies conducted over the past 5 years. Literature analysis showed that sirtuin 6, epigenetically modulating gene transcription and changing protein function, is involved in the main mechanisms of aging and related cardiovascular diseases. Thus, studying the effects of sirtuin 6 will provide a more detailed understanding of complex interaction, systemic factors and the development of cardiovascular pathology.
About the Authors
Yu. O. Ostanina
Novosibirsk State Medical University
Russian Federation
Russian Federation
Novosibirsk
D. A. Yakhontov
Novosibirsk State Medical University
Russian Federation
Russian Federation
Novosibirsk
D. A. Ufilina
Novosibirsk State Medical University
Russian Federation
Russian Federation
Novosibirsk
References
1. Savitskiy DV, Linkova NS, Kozhevnikova EO, et al. Sirtuins and chemokines as markers of replicative and induced senescence of human endotheliocytes. Acta Biomedica Scientifica. 2022;7(5-2):12-20. (In Russ.) doi:10.29413/ABS.2022-7.5-2.2.
2. Aitbaev KA, Murkamilov IT, Murkamilova ZA, et al. Epigenetic Mechanisms of Cardioprotection: Focus is on Activation of Sirtuins. The Russian Archives of Internal Medicine. 2021;11(6):424-32. (In Russ.) doi:10.20514/2226-6704-2021-11-6-424-432.
3. Safonova EA, Sukmanova IA. Myocardial infarction without obstructive coronary artery disease (MINOCA). Clinical Medicine. 2020;98(2):89-97. (In Russ.) doi:10.30629/0023-2149-2020-98-2-89-97.
4. Yakhontov DA, Ostanina JO. Early vascular aging syndrome in young and middle age patients with hypertension and coronary artery disease. Medical alphabet. 2018;1(3):33-6. (In Russ.)
5. Samoilova EM, Romanov SE, Chudakova DA, et al. Role of sirtuins in epigenetic regulation and aging control. Vavilovskii Zhurnal Genet Selektsii. 2024;28(2):215-27. (In Russ.) doi:10.18699/vjgb-24-26.
6. Aitbaev KA, Murkamilov IT, Murkamilova ZA, et al. Regulation of the Immune System in Aging: Focus on Epigenetic Mechanisms. The Russian Archives of Internal Medicine. 2022;12(1):35-44. (In Russ.) doi:10.20514/2226-6704-2022-12-1-35-44.
7. Nilsson PM, Lurbe E, Laurent S.The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome. J Hypertens. 2008;26(6):1049-57. doi:10.1097/HJH.0b013e3282f82c3e.
8. Rotar OP, Boiarinova MA, Tolkunova KM, et al. Vascular aging phenotypes in Russian population — biological, social, and behavioral determinants. Cardiovascular Therapy and Prevention. 2021; 20(5):2970. (In Russ.) doi:10.15829/1728-8800-2021-2970.
9. Nedogoda SV, Salasyuk AS, Barykina IN, et al. Early vascular aging in patients with metabolic syndrome: features of the course and diagnosis. South Russian Journal of Therapeutic Practice. 2021; 2(1):50-62. (In Russ.) doi:10.21886/2712-8156-2021-2-1-50-62.
10. Ziętara P, Dziewięcka M, Augustyniak M.Why Is Longevity Still a Scientific Mystery? Sirtuins-Past, Present and Future. Int J Mol Sci. 2022;24(1):728. doi:10.3390/ijms24010728.
11. Zhao Y, Bai X, Jia X, et al. Age-related changes of human serum Sirtuin6 in adults. BMC Geriatr. 2021;21(1):452. doi:10.1186/s12877-021-02399-0.
12. Chepurnova NS, Yushchuk VN, Kozaeva OA, et al. Genetic predictors of vascular aging. Modern problems of science and education. 2022;(6-2):3. (In Russ.) doi:10.17513/spno.32111.
13. Onn L, Portillo M, Ilic S, et al. SIRT6 is a DNA double-strand break sensor. Elife. 2020;9:e51636. doi:10.7554/eLife.51636.
14. Tian X, Firsanov D, Zhang Z, et al. SIRT6 is responsible for more efficient DNA double-strand break repair in long-lived species. Cell. 2019;177:622-38.e22. doi:10.1016/j.cell.2019.03.043.
15. Salakhov RR, Ponasenko AV. Telomere length and cardiovascular diseases. Complex Issues of Cardiovascular Diseases. 2018; 7(4S):101-7. (In Russ.) doi:10.17802/2306-1278-2018-7-4S-101-107.
16. Ostanina JO, Yakhontov DA. Telomere length in patients with coronary heart disease of different age groups. Bulletin of modern clinical medicine. 2018;11(1):44-9. (In Russ.) doi:10.20969/VSKM.2018.11(1).44-49.
17. Asanov MA, Poddubnyak AO, Ponasenko AV. Relationship between telomere length and markers of inflammation in the pre- and postoperative period of patients with coronary artery disease. Complex Issues of Cardiovascular Diseases. 2024;13(3):28-36. (In Russ.) doi:10.17802/2306-1278-2024-13-3-28-36.
18. Doroshсhuk NA, Lankin VZ, Tikhaze AK, et al. Telomere length as a biomarker of the risk of cardiovascular complications in patients with coronary heart disease. Terapevticheskii Arkhiv. 2021; 93(1):20-4. (In Russ.) doi:10.26442/00403660.2021.01.200588.
19. Pukhalskaya AE, Kvetnoy IM, Linkova NS, et al. Sirtuins and aging. Advances in physiological sciences. 2022;53(1):16-27. (In Russ.) doi:10.31857/S0301179821040056.
20. Aronov DM, Drapkina OM, Bubnova MG. Role of genetic factors (biology of telomeres) in cardiac rehabilitation. Cardiovascular Therapy and Prevention. 2022;21(6):3272. (In Russ.) doi:10.15829/1728-8800-2022-3272.
21. Wu QJ, Zhang TN, Chen HH, et al. The sirtuin family in health and disease. Signal Transduct Target Ther. 2022;7(1):402. doi:10.1038/s41392-022-01257-8.
22. Zenkov NK, Kozhin PM, Chechushkov AV, et al. Oxidative stress during aging. Advances in Gerontology. 2020;33:10-22. (In Russ.) doi:10.34922/AE.2020.33.1.001.
23. Metelskaya VA, Timofeev YS, Neshkova EA, et al. Inflammatory aging. Part 2. Are there diagnostic biomarkers available. Russian Journal of Preventive Medicine. 2025;28(1):89-95. (In Russ.) doi:10.17116/profmed20252801189.
24. Krivoshapova KE, Masenko VL, Bazdyrev ED, et al. Osteosarcopenic obesity in cardiovascular patients. Controversial and open issues. Cardiovascular Therapy and Prevention. 2021;20(6):2787. (In Russ.) doi:10.15829/1728-8800-2021-2787.
25. Mamatov AU, Polupanov AG, Kakeev BA, et al. Gender and age factors associated with the development of obesity. The Scientific Heritage. 2021;(68-2(68):46-56. (In Russ.) doi:10.24412/9215-0365-2021-68-2-46-56.
26. Santos AL, Sinha S. Obesity and aging: molecular mechanisms and therapeutic approaches. Ageing Res Rev. 2021;67:101268. doi:10.1016/j.arr.2021.101268.
27. Kuang J, Zhang Y, Liu Q, et al. Fat-specific Sirt6 ablation sensitizes mice to high-fat diet-induced obesity and insulin resistance by inhibiting lipolysis. Diabetes. 2017;66:1159-71. doi:10.2337/db16-1225.
28. Martinez-Jimenez V, Cortez-Espinosa N, Rodriguez-Varela E, et al. Altered levels of sirtuin genes (SIRT1, SIRT2, SIRT3 and SIRT6) and their target genes in adipose tissue from individual with obesity. Diabetes Metab Syndr. 2019;13:582-9. doi:10.1016/j.dsx.2018.11.011.
29. Mostoslavsky R, Chua KF, Lombard DB, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006;124:315-29. doi:10.1016/j.cell.2005.11.044.
30. Wei Z, Yang B, Wang H, et al. Caloric restriction, Sirtuins, and cardiovascular diseases. Chin Med J (Engl). 2024;137(8):921-35. doi:10.1097/CM9.0000000000003056.
31. He Y, Yang G, Sun L, et al. SIRT6 inhibits inflammatory response through regulation of NRF2 in vascular endothelial cells. Int Immunopharmacol. 2021;99:107926. doi:10.1016/j.intimp.2021.107926.
32. Arsiwala T, Pahla J, van Tits LJ, et al. Sirt6 deletion in bone marrow-derived cells increases atherosclerosis — Central role of macrophage scavenger receptor 1. J Mol Cell Cardiol. 2020;139: 24-32. doi:10.1016/j.yjmcc.2020.01.002.
33. Finigan A, Figg NL, Uryga AK, et al. SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis. Circ Res. 2021;128:474-91. doi:10.1161/CIRCRESAHA.120.318353.
34. Shi J, Yang Y, Cheng A, et al. Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol. 2020;319(3):H613-31. doi:10.1152/ajpheart.00220.2020.
35. Savitsky DV, Linkova NS, Kozhevnikova EO, et al. SASP of endothelium and vascular smooth muscle cells: role in the pathogenesis and therapy of atherosclerosis. Molecular medicine. 2022;(4):9- 15. (In Russ.) doi:10.29296/24999490-2022-04-02.
36. Sinitsky MY, Sinitskaya AN, Shishkova DV, et al. Gene expression of proinflammatory cytokines in human coronary artery smooth muscle cells exposed to alkylating mutagen. Complex Issues of Cardiovascular Diseases. 2022;11(4):158-66. (In Russ.) doi:10.17802/2306-1278-2022-11-4-158-166.
37. Raj S, Dsouza LA, Singh SP, et al. Sirt6 deacetylase: a potential key regulator in the prevention of obesity, diabetes and neurodegenerative disease. Front Pharmacol. 2020;11:598326. doi:10.3389/fphar.2020.598326.
38. Gaul DS, Calatayud N, Pahla J, et al. Endothelial SIRT6 deficiency promotes arterial thrombosis in mice. J Mol Cell Cardiol. 2023;174:56-62. doi:10.1016/j.yjmcc.2022.11.005.
39. Fiorentino F, Carafa V, Favale G, et al. The two-faced role of SIRT6 in cancer. Cancers (Basel) 2021;13:1156. doi:10.3390/cancers13051156.
Supplementary files
Review
For citations:
Ostanina Yu.O., Yakhontov D.A., Ufilina D.A. Role of sirtuin 6 in early vascular aging in young and middle-aged patients with coronary artery disease (literature review). Cardiovascular Therapy and Prevention. 2025;24(8):4370. (In Russ.) https://doi.org/10.15829/1728-8800-2025-4370. EDN: OCWUBS
Views:
159
Email this article 
